Deciding Whether to Communicate a Cancer Diagnosis at Work.

Am J Pharm Educ

Touro College of Pharmacy, Department of Social Behavioral & Administrative Sciences, New York, NY, USA.

Published: August 2025


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

With rising cancer rates, a faculty or staff member may face a personal cancer diagnosis. As the news may be unexpected, faculty and staff members with cancer have several decisions to make, including whether or not to tell colleagues or students and how to deliver the news. Guidance for these types of decisions and conversations is rarely discussed in the pharmacy literature; however, it is an important topic to consider as a cancer diagnosis can have a significant impact on the faculty or staff member, the work environment, and the college or school of pharmacy overall. It is important to raise awareness of the issues facing faculty or staff members with a cancer diagnosis in order to help support them.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ajpe.2025.101435DOI Listing

Publication Analysis

Top Keywords

cancer diagnosis
16
faculty staff
16
staff member
8
staff members
8
members cancer
8
cancer
6
deciding communicate
4
communicate cancer
4
diagnosis
4
diagnosis work
4

Similar Publications

Objective: The cachexia index (CXI) demonstrates potential as both a diagnostic tool for cachexia and a prognostic tool for survival in cancer. However, CXI's predictive value has not been verified in cervical cancer. The purpose of this study is to investigate the prognostic value of the CXI in patients with cervical cancer treated with radiotherapy.

View Article and Find Full Text PDF

Endothelial Colony-Forming Cells (ECFCs) are recognized as key vasculogenic progenitors in humans and serve as valuable liquid biopsies for diagnosing and studying vascular disorders. In a groundbreaking study, Anceschi et al. present a novel, integrative strategy that combines ECFCs loaded with gold nanorods (AuNRs) to enhance tumor radiosensitization through localized hyperthermia.

View Article and Find Full Text PDF

ASO Practice Guidelines Series: Soft Tissue Sarcoma of the Extremities and Superficial Trunk.

Ann Surg Oncol

September 2025

Division of Surgical Oncology, Department of Surgery, Winship Cancer Institute, Emory University, Atlanta, GA, USA.

Soft tissue sarcomas (STS) are a heterogeneous group of rare malignant tumors arising from mesenchymal tissues, with extremity and superficial trunk STS (eSTS) comprising the majority of cases. The management of localized eSTS requires a multidisciplinary approach to optimize oncologic and functional outcomes. This review outlines the natural history, diagnostic workup, and treatment principles for localized eSTS, emphasizing the role of histology-specific considerations in guiding management strategies.

View Article and Find Full Text PDF

Purpose: Lung cancer is currently the most common malignant tumor worldwide and one of the leading causes of cancer-related deaths, posing a serious threat to human health. MicroRNAs (miRNAs) are a class of endogenous non-coding small RNA molecules that regulate gene expression and are involved in various biological processes associated with lung cancer. Understanding the mechanisms of lung carcinogenesis and detecting disease biomarkers may enable early diagnosis of lung cancer.

View Article and Find Full Text PDF

Purpose: Patients diagnosed with high-grade gliomas (HGG) often experience substantial psychosocial dis-tress. However, due to neurological and neurocognitive deficits its assessment remains challenging, and needs remain unmet. We compared a novel face-to-face assessment during doctor-patient conversations with questionnaire-based screening.

View Article and Find Full Text PDF